Complex Segmentectomy in the Treatment of Stage IA Non-Small-Cell Lung Cancer

Two groups of Clinical Stage IA lung cancer patients were retrospectively investigated. Ninety-nine patients underwent complex segmentectomy, and 94 patients underwent location-adjusted lobectomy. The results of these two different strategies were compared. Outcomes have been comparable regarding mortality, morbidity, overall survival, and recurrence-free survival rates.

 The authors concluded that complex segmentectomy can provide comparable outcomes in Stage IA lung cancer treatment.